Trials / Completed
CompletedNCT06975098
A Journey to Balance: Development and Validation of Individualized Life Balance Intervention for Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Chung Shan Medical University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical intervention study is to enhance life balance in community-dwelling individuals with depression. The main question it aims to answer is: Can an individualized life balance intervention, combining group sessions and telephone support, effectively improve life balance, time management, functional roles, quality of life, and reduce depression severity in individuals with depression? Participants will: Complete baseline assessments including demographics, illness-related information, and the Canadian Occupational Performance Measure (COPM). Participate in four weekly, two-hour group sessions tailored to their individual needs identified through the COPM assessment. Receive telephone support 1-3 days before each group session. Complete post-intervention assessments immediately after the four-week program and again one month later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Life balance intervention group program | Life balance intervention group program is a four-week group intervention program for individuals with depression, with sessions lasting two hours each week. The program will address life balance issues such as daily scheduling, time management, stress coping, emotional regulation, and social participation, and will be tailored to individual patient needs. Through group discussions and practical exercises, participants will learn to apply these skills in their daily lives. Telephone support will be provided during the intervention period to offer emotional support and enhance participation rates. |
Timeline
- Start date
- 2024-09-23
- Primary completion
- 2025-01-13
- Completion
- 2025-06-30
- First posted
- 2025-05-16
- Last updated
- 2025-08-13
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06975098. Inclusion in this directory is not an endorsement.